Radioiodine therapy of Graves' disease-Reference-Cited by-同舟云学术

Radioiodine therapy of Graves' disease

Published:2021-04 Issue:2 Volume:65 Page:
ISSN:1824-4785
Container-title:The Quarterly Journal of Nuclear Medicine and Molecular Imaging
language:
Short-container-title:Q J Nucl Med Mol Imaging

Author:

PICCARDO Arnoldo,UGOLINI Martina,ALTRINETTI Vania,RIGHI Sergio,FIZ Francesco,FOPPIANI Luca,GIOVANELLA Luca

Publisher

Edizioni Minerva Medica

Subject

Radiology, Nuclear Medicine and imaging

Link

https://www.minervamedica.it/pdf.php?cod=R39Y2021N02A0132

Reference43 articles.

1. The Role of Nuclear Medicine in the Clinical Management of Benign Thyroid Disorders, Part 1: Hyperthyroidism

2. Smoking and thyroid

3. Human Thyroid Adenyl Cyclase-Stimulating Activity in Immunoglobulin G of Patients with Graves' Disease

4. Kahaly a Luigi Bartalena b Lazlo Hegedüs c Laurence Leenhardt d Kris Poppe e Simon H. Pearce 2018 European Thyroid Association Guideline for the Management of Graves';George J;Hyperthyroidism Eur Thyroid J,2018

5. Radioiodine Therapy in Benign Thyroid Diseases: Effects, Side Effects, and Factors Affecting Therapeutic Outcome

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nomogram construction and evaluation for predicting non-remission after a single radioactive iodine therapy for Graves’ hyperthyroidism: a retrospective cohort study;Frontiers in Endocrinology;2024-08-21

2. Radiofrequency ablation versus radioactive iodine: the race for the best cure;European Journal of Nuclear Medicine and Molecular Imaging;2024-03-15

3. The influence of thionamides on intra-thyroidal uptake of 131I during radioiodine-131 treatment of Graves’ disease;Scientific Reports;2023-12-01

4. Curcumin induces mitophagy by promoting mitochondrial succinate dehydrogenase activity and sensitizes human papillary thyroid carcinoma BCPAP cells to radioiodine treatment;Toxicology in Vitro;2023-12

5. Quality of life and decision regret in patients with late‐hypothyroidism after radioiodine treatment for Graves' disease;Clinical Endocrinology;2023-11-14